Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta-analysis

89Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Background: Trichotillomania (TTM) is a difficult-to-treat psychiatric condition with no first-line medications approved by the Food and Drug Administration. Individuals with TTM often feel that clinicians know little about this disorder. Here, we present an updated meta-analysis of randomized controlled trials (RCTs) examining treatments for TTM. Methods: Pubmed, PsychINFO, Embase, and CENTRAL were searched with the terms “Trichotillomania OR Hair Pulling Disorder” to identify randomized controlled clinical trials evaluating treatments for TTM. Results: Twenty-four trials involving 26 comparisons and 857 participants were included in this meta-analysis. Behavioral therapy with habit-reversal training components (BT-HRT) demonstrated a large benefit compared to control conditions (standardized mean difference [SMD] [95% CI] = −1.22 [−1.71, −0.73], p

Cite

CITATION STYLE

APA

Farhat, L. C., Olfson, E., Nasir, M., Levine, J. L. S., Li, F., Miguel, E. C., & Bloch, M. H. (2020, August 1). Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta-analysis. Depression and Anxiety. Blackwell Publishing Inc. https://doi.org/10.1002/da.23028

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free